Look for:

Our offer for

Research Detail

2023/03/16 / Erste Group Research

Outperformance of US markets begins

In the current market situation characterized by increased uncertainty, the US leading indices are again showing relative strength compared with the European stock market. The outperformance of European markets, which has lasted since 4Q 2022, has probably come to an end.

An important reason for the incipient relative strength of the US market is the expected higher earnings growth of US companies. Profits are expected to rise by +9.9% (y/y) in 2023. European companies are expected to be able to increase profits by only +0.6% (y/y).

Rating Changes: Hershey, Ryanair, Royal Bank of Canada, ICICI Bank, KBC

PDF Download Download PDF (7.8MB)

General information

AuthorErste Group Research
Date2023/03/16
Languageen
Product nameRecommendation List
Topic in focusEquities
Economy in focusEurozone, Germany, Poland, Switzerland, United Kingdom, United States
Currency in focusBritish Pound, Euro, Polish Zloty, Swiss Franc, US Dollar
Sector in focusAutomobiles & Parts, Banks, Basic Resources, Chemicals, Construction & Material, Financial Services, Food & Beverage, Health Care, Industrial Goods & Services, Insurance, Media, Oil & Gas, Personal & Household Goods, Retail, Technology, Telecommunications, Travel & Leisure, Utilities
Download

Related financial instruments

Page 2 of 6
Name  ISIN# Erste Group products
BHP GroupGB00BH0P3Z910
BMWDE00051900033
BNP ParibasFR00001311040
Booking HoldingsUS09857L10890
BPGB00079805910
Bristol-Myers Squibb US11012210830
CaterpillarUS14912310150
Chevron US16676410050
China Construction BankCNE1000002H10
Cie Financiere RichemontCH02104833320
CiscoUS17275R10230
CitigroupUS17296742420
Coca-ColaUS19121610070
Colgate-PalmoliveUS19416210390
ColoplastDK00604485950
ConocoPhillipsUS20825C10450
Daikin Industries JP34818000050
DanoneFR00001206440
Deere & CoUS24419910540
Deutsche BankDE00051400085
Deutsche BoerseDE00058100550
Deutsche TelekomDE00055575080
DHL GroupDE00055520040
DiageoGB00023740060
Edwards LifesciencesUS28176E10820



Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer